( views:, downloads: )
LU Xue-lian()
LIU Wei-da()
Journal Title:
Volume 32, Issue 02, 2006
Key Word:


  • [1]Ajello L.Hyalohyphomycosis and phaeohyphomycosis:two global disease entities of public health importance.Eur J Epidemiol,1986,2:243-251.
  • [2]Pfaller MA,Diekema DJ.Rare and emerging opportunistic fungal pathogens:concern for resistance beyond Candida albicans and Aspergillus fumigatus.J Clin Microbiol,2004,42:4419-31.
  • [3]Walsh TJ,Groll A,Hiemenz J,et al.Infections due to emerging and uncommon medically important fungal pathogens.Clin Microbiol Infect,2004,10(Suppl 1):48-66.
  • [4]Dignani MC,Anaissie E.Human fusariosis.Clin Microbiol Infect,2004,10(Suppl 1):67-75.
  • [5]Boutati EI,Anaissie EJ.Fusarium,a significant emerging pathogen in patients with hematologic malignancy:ten years' experience at a cancer center and implications for management.Blood,1997,90:999-1008.
  • [6]Girmenia C,Pagano L,Corvatta L,et al.The epidemiology of fusariosis in patients with haematological diseases.Gimema Infection Programme.Br J Haematol,2000,111:272-276.
  • [7]Anaissie EJ,Kuchar RT,Rex JH,et al.Fusariosis associated with pathogenic fusarium species colonization of a hospital water system:a new paradigm for the epidemiology of opportunistic mold infections.Clin Infect Dis,2001,33:1871-1878.
  • [8]Guerrero A,Torres P,Duran MT,et al.Airborne outbreak ofnosocomial Scedosporium prolificans infection.Lancet,2001,357:1267-1268.
  • [9]Pettit TH,Olson R J,Foos RY,et al.Fungal endophthalmitis following intraocular lens implantation.A surgical epidemic.Arch Ophthalmol,1980,98:1025-1039.
  • [10]Itin PH,Frei R,Lautenschlager S,et al.Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed.J Am Acad Dermatol,1998,39:401-409.
  • [11]Hall VC,Goyal S,Davis MD,et al.Uutaneous hyalohyphomycosis caused by Paecilomyces lilacinus:report of three cases and review of the literature.Int J Dermatol,2004,43:648-653.
  • [12]Maertens J,Lagrou K,Deweerdt H,et al.Disseminated infection by Scedosporium prolificans:an emerging fatality among haematology patients.Case report and review.Ann Hematol,2000,79:340-344.
  • [13]Liu K,Howell DN,Perfect JR,et al.Morphologic criteria for the preliminary identification of Fusarium,Paecilomyces,and Acremonium species by histopathology.Am J Clin Pathol,1998,109:45.
  • [14]Kan SF,Tsai TH,Hu CH,et al.Cutaneous hyalohyphomycosis caused by Acrcmonium in an immunocompetent patient.Br J Dermatol,2004,150:789-790.
  • [15]Walsh TJ,Peter J,McGough DA,et al.Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.Antimicrob Agents Chemother,1995,39:1361-1364.
  • [16]Gupta AK,Baran R,Summerbell RC.Fusarium infections of the skin.Curr Opin Infect Dis,2000,13:121-128.
  • [17]Martin CA,Roberts S,Greenberg RN.Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.Clin Infect Dis,2002,35:e78-81.
  • [18]Choi DM,Goldstein MH,Salierno A,et al.Fungal keratitis in a daily disposable soft contact lens wearer.CLAO J,2001,27:111-112.
  • [19]Rota S,Marchesi D,Farina C,et al.Trichoderma pseudokoningii peritonitis in automated peritoneal dialysis patient successfully treated by early catheter removal.Perit Dial Int,2000,20:91-93.
  • [20]Nesky MA,McDougal EC,Peacock Jr JE.Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage:case report and literature review of central nervous system pseudallescheriasis.Clin Infect Dis,2000,31:673-677.
  • [21]Nucci M,Anaissie E.Cutaneous infection by Fusarium species in healthy and immunocompromised hosts:implications for diagnosis and management.Clin Infect Dis,2002,35:909-920.
  • [22]Kaufman L,Standard PG,Jalbert M,et al.Immunohistologic identification of Aspergillus spp.and other hyaline fungi by using polyclonal fluorescent antibodies.J Clin Microbiol,1997,35:2206-2209.
  • [23]Hayden RT,Isotalo PA,Parrett T,et al.In situ hybridization for the differentiation of Aspergillus,Fusarium,and Pseudallescheria species in tissue section.Diagn Mol Pathol,2003,12:21-26.
  • [24]Diekema DJ,Messer SA,Hollis RJ,et al.Activities of caspofungin,itraconazole,posaconazole,ravuconazole,voriconazole,and amphotericin B against 448 recent clinical isolates of filamentous fungi.J Clin Microbiol,2003,41:3623-3626.
  • [25]Espinel-IngroffA.Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.J Clin Microbiol,1998,36:2950-2956.
  • [26]Odabasi Z,Paetznick VL,Rodriguez JR,et al.In vitro activity of anidulafungin against selected clinically important mold isolates.Antimicrob Agents Chemother,2004,48:1912-1915.
  • [27]Safdar A.Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus:rapid response to treatment with caspofungin and itraconazole.Clin Infect Dis,2002,34:1415-1417.
  • [28]Richter S,Cormican MG,Pfaller MA,et al.Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient:species identification and review of the literature.J Clin Microbiol,1999,37:1154-1160.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn